Business Context and Reporting Period
Company: Cree, Inc. (Note: The filing metadata references "Wolfspeed," but the document text identifies the registrant as Cree, Inc.)
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Quarter and six months ended December 23, 2001 (Fiscal 2002).
Business Overview: Cree is a leader in silicon carbide (SiC) and gallium nitride (GaN) semiconductors. Operations are divided into two segments: the Cree segment (LEDs, SiC wafers, materials) and the UltraRF segment (RF power semiconductors acquired in late 2000). The company faces significant competition and is heavily reliant on a few key customers, particularly Spectrian for the UltraRF segment.
Key Financial Metrics
| Metric (in thousands) | 3 Months Ended Dec 23, 2001 |
3 Months Ended Dec 24, 2000 |
6 Months Ended Dec 23, 2001 |
6 Months Ended Dec 24, 2000 |
|---|---|---|---|---|
| Total Revenue | $41,092 | $41,494 | $84,258 | $79,136 |
| Gross Profit | $19,375 | $22,074 | $39,279 | $42,640 |
| Gross Margin % | 47% | 53% | 47% | 54% |
| Net (Loss) Income | $(17,376) | $13,861 | $(10,915) | $26,515 |
| Diluted EPS | $(0.24) | $0.18 | $(0.15) | $0.35 |
| Cash & Equivalents | $144,337 | N/A | N/A | N/A |
| Working Capital | $221,942 | N/A | N/A | N/A |
| Operating Cash Flow (6mo) | $23,846 | N/A | $23,846 | $36,540 |
Note: The company reported a net loss for the quarter and six-month period primarily due to non-recurring impairment charges.
Material Changes vs. Prior Period
- Revenue: Quarterly revenue decreased 1% to $41.1 million, while six-month revenue increased 6.6% to $84.3 million. The six-month increase was driven by the inclusion of UltraRF revenue ($17.5 million), which had no comparable prior-year data. Excluding UltraRF, organic revenue declined.
- Product Mix & Pricing: LED revenue declined 19% (quarter) and 16% (six months) despite volume increases, due to a 26-28% drop in average selling prices from contractual volume discounts. Gemstone material sales collapsed (down 84% quarter-over-quarter) with nominal sales to Charles & Colvard.
- Impairment Charges: The company recorded significant non-cash charges:
- Property & Equipment: $18.1 million impairment due to technology shifts (transition to 3" wafers) and obsolescence of non-preferred reactor equipment.
- Investments: $12.4 million "other-than-temporary" impairment on long-term investments in privately held companies.
- Operating Expenses: R&D expenses surged 191% (quarter) and 148% (six months) due to UltraRF integration and increased internal funding. SG&A expenses rose 87% (quarter) largely due to legal costs associated with intellectual property litigation.
- Interest Income: Declined 69% (quarter) and 62% (six months) due to lower interest rates on cash equivalents.
Outlook, Risks, and Management Commentary
- Product Pipeline: Management introduced "X-Bright" LED technology, targeting 50% higher brightness. Samples were shipped in December 2001, with significant sales expected in the fourth quarter of fiscal 2002 following a design-in cycle. MegaBright products now represent 37% of LED revenue.
- Customer Concentration: Over 90% of UltraRF sales are to Spectrian under a supply contract expiring December 31, 2002. Management is actively pursuing design wins with new customers to diversify revenue.
- Legal Proceedings: Significant ongoing litigation with Nichia Corporation regarding patent infringement in Japan and the U.S. While a Tokyo court recently dismissed a suit regarding high-brightness LEDs, appeals are pending. The company faces counterclaims regarding antitrust violations and trade secrets.
- Liquidity: The company maintains strong liquidity with $144.3 million in cash and equivalents and $221.9 million in working capital. Management states resources are adequate to fund near-term capital expenditures and operations.
- Stock Repurchase: The company repurchased 705,000 shares for $10.6 million during the six-month period. The program expired in January 2002, but management intends to seek renewal.
Investor Verification Checklist
- Impairment Validity: Verify the rationale and magnitude of the $18.1 million equipment write-off and $12.4 million investment impairment to ensure they are non-recurring.
- Spectrian Contract Renewal: Assess the risk of revenue loss post-December 2002 when the UltraRF supply agreement with Spectrian expires.
- LED Pricing Pressure: Monitor average selling price trends for LEDs to determine if volume growth can offset continued price erosion.
- Legal Exposure: Track the status of the Nichia patent litigation appeals and the antitrust counterclaims, as adverse rulings could impact future sales or incur significant damages.
- X-Bright Adoption: Confirm the timeline for customer design-ins and revenue recognition for the new X-Bright LED product line.